meddevicedb.com FDA Device Reference

HEMOSIL LA POSITIVE CONTROL & HEMOSIL LA NEGATIVE CONTROL

K113211 Class II Traditional
Decision Date
2012-01-04
Sponsor / Applicant
Instrumentation Laboratory CO

Technical Specification

510(k) Submission ID K113211
Product Code GGN
Medical Specialty / Panel Hematology
Regulation Citation 21 CFR 864.5425
Decision Date 2012-01-04
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

HEMOSIL LA POSITIVE CONTROL & HEMOSIL LA NEGATIVE CONTROL received FDA 510(k) clearance under submission number K113211, sponsored by Instrumentation Laboratory CO. The device was reviewed via the Traditional premarket notification pathway and assigned to the Hematology review panel. The statutory decision date of record is 2012-01-04.

Classification & Regulation

This clearance is catalogued under FDA product code GGN and 21 CFR 864.5425, within the Hematology review panel as a Class II device.